API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.dddmag.com/news/2017/07/cytrx-nantcell-strike-licensing-agreement-aldoxorubicin
http://www.fiercebiotech.com/biotech/soon-shiong-s-nantcell-356m-deal-for-underperforming-cytrx-cancer-drug?utm_source=internal&utm_medium=rss
http://www.nasdaq.com/article/cytrx-gets-clarity-from-fda-for-aldoxorubicin-nda-shares-up-cm776780
http://in.reuters.com/article/brief-cytrx-says-fda-agreement-on-regula-idINASA09J5R
http://www.biospace.com/News/cytrx-plans-to-file-nda-for-once-failed-sarcoma/440456/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews